Joshua Dennerlein analyst BAML

Currently out of the existing stock ratings of Joshua Dennerlein, 32 are a SELL (19.88%), 62 are a HOLD (38.51%), 67 are a BUY (41.61%).

Joshua Dennerlein

Work Performance Price Targets & Ratings Chart

Analyst Joshua Dennerlein, currently employed at BAML, has had 65.94% of price targets met with an average potential upside of 25.84%, reached in 463 days on average.

Joshua Dennerlein has documented 304 price targets and ratings displayed on 36 stocks. The coverage is on Industrials, Financial Services sectors.

Most recent stock forecast was given on CTAS, Cintas at 15-Jul-2026.

Wall Street Analyst Joshua Dennerlein

Analyst best performing recommendations are on AHR (AMERICAN HEALTHCARE REIT).
The best stock recommendation documented was for AHR (AMERICAN HEALTHCARE REIT) on 8/8/2024. The price target of $19 was fulfilled within 14 days with a profit of $3.19 (20.18%), with a performance score of 14.41.

Average potential price target upside

COLD Americold Realty Trust EPRT MPW Medical Properties Trust OHI PEAK SBRA SRC VTR WELL ADC CPT Camden Property Trust DOC Physicians Realty Trust NNN GTY NTST SAFE VER EPR MAA Mid-America Apartment Communities O SUI Sun Communities WPC ESS Essex Property Trust AHR American Healthcare REIT CTAS Cintas EFX FICO FVR KW Kennedy-Wilson Holdings LINE MCO Moodys MP MSCI SR UDR VRE Veris Residential

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 31-Mar-2026

$19

$3.1 (19.50%)

$15

6 days ago
(12-Nov-2026)

2/4 (50%)

$3.1 (19.50%)

30

Buy Since 20-Sep-2026

$19

$3.1 (19.50%)

$18

13 days ago
(05-Nov-2026)

4/15 (26.67%)

$2.99 (18.68%)

69

Hold Since 13-Oct-2025

$14

$-1.9 (-11.95%)

$16

30 days ago
(19-Oct-2026)

4/5 (80%)

$-0.1 (-0.71%)

103

Hold Since 04-Sep-2025

$16

$0.1 (0.63%)

$16

1 months 17 days ago
(01-Oct-2026)

7/14 (50%)

$2.03 (14.53%)

138

Sell Since 13-Nov-2025

$16

$0.1 (0.63%)

$14

1 months 26 days ago
(23-Sep-2026)

5/11 (45.45%)

$1.87 (13.23%)

123

Show more analysts

Please expand the browser size to see the chart

Which stock is Joshua Dennerlein most bullish on?

Potential upside of $32.32 has been obtained for CTAS (CINTAS)

What Year was the first public recommendation made by Joshua Dennerlein?

On 2013
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?